Results 1 to 10 of about 30,996 (259)
Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study. [PDF]
PLoS MedicineBackgroundHallucinogen use for both recreational and medical purposes is rapidly increasing globally, raising concerns about potential adverse effects.
Daniel T Myran +6 more
doaj +2 more sources
Therapeutic Advances in Psychopharmacology, 2019 Background: Recognition of emotions in facial expressions (REFE) is a key aspect of social cognition. Anxiety and mood disorders are associated with deficits in REFE, and anxiolytics and antidepressants reverse these deficits.
Juliana M. Rocha +6 more
doaj +2 more sources
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey. [PDF]
Psychedelic Med (New Rochelle), 2023 Background: Psilocybin, a classic hallucinogen, may eventually be approved by the United States Food and Drug Administration for treatment-resistant depression.
Barnett BS +7 more
europepmc +2 more sources
Modulation of Social Cognition via Hallucinogens and “Entactogens”
Frontiers in Psychiatry, 2019 Social cognition is a fundamental ability in human everyday lives. Deficits in social functioning also represent a core aspect of many psychiatric disorders.
Katrin H. Preller, Franz X. Vollenweider
doaj +2 more sources
Risk Management and Healthcare Policy, 2021 Rafael Guimarães dos Santos,1– 3 José Carlos Bouso,1,3,4 Juliana Mendes Rocha,1 Giordano Novak Rossi,1 Jaime E Hallak1,2 1Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo ...
dos Santos RG +4 more
doaj +2 more sources
Frontiers in Neuroscience, 2018 Ever since the modern rediscovery of psychedelic substances by Western society, several authors have independently proposed that their effects bear a high resemblance to the dreams and dreamlike experiences occurring naturally during the sleep-wake cycle.
Camila Sanz +5 more
doaj +2 more sources
The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews [PDF]
Brain SciencesBackground: Substance use disorders (SUDs) are highly prevalent, affecting over 48.5 million Americans. Available treatments for SUD remain insufficient, and many patients do not respond to existing interventions despite adequate adherence to treatments.
Sabrina Correa da Costa +7 more
doaj +2 more sources
Pediatrics and Neonatology, 2023 Background: Infants exposed prenatally to drugs of substance use are at increased risk for seizures, strabismus, feeding difficulty, and neurodevelopmental delays. Exposed preterm infants may have additional morbidities related to prematurity.
Subhash Puthuraya +5 more
doaj +1 more source
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Frontiers in Psychiatry, 2021 Addressing global mental health is a major 21st-century challenge. Current treatments have recognized limitations; in this context, new ones that are prophylactic and effective across diagnostic boundaries would represent a major advance.
Rita Kočárová +5 more
doaj +1 more source
Therapeutic effect of psilocybin in addiction: A systematic review
Frontiers in Psychiatry, 2023 BackgroundPsychedelic-assisted therapy [e.g., with lysergic acid diethylamide (LSD)] has shown promising results as treatment for substance use disorders (SUDs).
Pim B. van der Meer +18 more
doaj +1 more source